MedPath

Electronic-Nutrition-Optimizer for Personalized Prevention

Not Applicable
Completed
Conditions
Diabetes
Frailty
Cardiovascular Diseases
Hypertension
Dementia
Registration Number
NCT04866264
Lead Sponsor
Heike Bischoff-Ferrari
Brief Summary

This study aims to develop and validate a tool for immediate nutrition assessment and to test its user feasibility in routine clinical practice for health promotion.

Detailed Description

Small changes in diet have been shown to have an important impact on health and the risk of age-related chronic diseases, such as cardiovascular disease, diabetes, frailty and dementia. However, this knowledge has not yet been implemented into routine clinical practice, because practical tools that allow a comprehensive nutrition assessment in the clinical care setting are missing. In addition, doctors are generally not educated in giving nutritional advice to patients. In this pilot project, we aim to push forward and enable the potential of nutrition as a core primary prevention strategy for people at risk of developing chronic diseases. This will be achieved by using, as a stepping stone, the electronic 216-food-item food frequency questionnaire which was developed for the European DO-HEALTH study and was tested in over 2000 adults. The investigators want to extend this tool to not only capture the personal dietary intake, but also to produce an immediate report, comparing the personal diet to the Mediterranean and MIND diet patterns and providing a patient's intake of protein and other nutrients. The report will additionally indicate the patient's diet-related, personalized risks of cardio-vascular disease, diabetes, frailty and cognitive decline, and recommend dietary changes to reduce these risks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
88
Inclusion Criteria
  1. Stable inpatients from the Department of heart surgery, or Center for senior trauma patient at the university hospital Zurich (inpatient group)
  2. Ambulatory volunteers who can visit the center for aging and mobility (CAM) independently ("outpatients" group)
  3. ≥50 years
Exclusion Criteria
  1. If already involved in another ongoing interventional clinical trial, except an interaction with this intervention can be excluded
  2. People with an impaired short-term memory (MMSE <24)
  3. Patients following a specific diet recommended by a medical professional, due to diseases such as diabetes, chronic diseases of the gastrointestinal tract, severe kidney disease, or patients allergic to the main components of the Mediterranean diet/MINDdiet (olive oil, nuts)
  4. Outpatients: HbA1C ≥6.5% Inpatients: HbA1C ≥6.5% or diagnosed diabetes mellitus if HbA1C is not available in KISIM
  5. BMI > 30 kg/m2
  6. Individuals per se not willing to change diet
  7. Instable clinical conditions (e.g. acute infection) at enrolment
  8. Patients with active cancer (except non-melanoma skin cancer) or current cancer treatment or any other advanced severe disease
  9. Living in a nursing home and/or receiving prepared meals (i.e. usually not eating home cooked meals)
  10. Inability to read and or speak German necessary to understand the instructions

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Perception questionnaire using system usability scaleBaseline

Feasibility Study (in- and outpatient group) Scale from 1 to 5, indicating 1 "not true", 5 "very true"

Subjective effectiveness questionnaire of eNutrition Optimizermonth 3 to 6

Feasibility Study (in- and outpatient group) Scale from 1 to 5, indicating 1 "not true", 5 "very true"

Secondary Outcome Measures
NameTimeMethod
waist-to-hip ratio6 months

Change in diet (outpatient group) and safety (outpatient group)

blood marker Non-HDL cholesterol (mmol/l)6 months

Validation Study (outpatient group)

blood marker Folate (µg/l)6 months

Validation Study (outpatient group)

blood marker Iron (µmol/l)6 months

Validation Study (outpatient group)

blood marker Soluble transferrin receptor (mg/l)6 months

Validation Study (outpatient group)

blood marker Vitamin B12 (ng/l)6 months

Validation Study (outpatient group)

blood marker Ferritin (µg/l)6 months

Validation Study (outpatient group)

24h diet recallsmonth 4 to 6

Validation Study (outpatient group)

blood marker Triglycerides (mmol/l)6 months

Validation Study (outpatient group)

blood marker Fasting glucose (mmol/l)6 months

Validation Study (outpatient group)

blood marker Interleukin-6 (pg/ml)6 months

Validation Study (outpatient group)

Dietary patterns assessed with the eNutrition Optimizer (based on a food frequency questionnaire), MIND diet score ranging from 0 to 15 with 0=worst, 15=best ; Med Diet score ranging from 0 to 55 with 0=worst, 15=best6 months

Change in diet (outpatient group)

blood marker HDL cholesterol (mmol/l)6 months

Validation Study (outpatient group)

blood marker Transferrin (µmol/l)6 months

Validation Study (outpatient group)

blood marker high sensitive-CRP (mg/l)6 months

Validation Study (outpatient group)

BMI6 months

Change in diet (outpatient group) and safety (outpatient group)

systolic and diastolic blood pressure6 months

Change in diet (outpatient group)

blood marker HbA1C (%)6 months

Validation Study (outpatient group)

Trial Locations

Locations (1)

Centre on Aging and Mobility, University of Zurich

🇨🇭

Zurich, ZH, Switzerland

Centre on Aging and Mobility, University of Zurich
🇨🇭Zurich, ZH, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.